Free Trial
NASDAQ:FMED

Fidelity Disruptive Medicine ETF (FMED) Price, Holdings, & News

$23.54 -0.13 (-0.53%)
Closing price 03:55 PM Eastern
Extended Trading
$23.56 +0.01 (+0.04%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Fidelity Disruptive Medicine ETF (NASDAQ:FMED)

Key Stats

Today's Range
$23.35
$23.62
50-Day Range
$23.01
$24.22
52-Week Range
$20.69
$26.79
Volume
3,590 shs
Average Volume
5,718 shs
Market Capitalization
$51.80 million
Assets Under Management
$52.71 million
Dividend Yield
0.47%
Net Expense Ratio
0.51%
Aggregate Rating
Moderate Buy

ETF Overview

Fidelity Disruptive Medicine ETF Expenses

TypeFMEDTheme ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.50%0.57%0.56%0.54%0.53%
Other Expenses0.01%0.57%0.56%0.52%0.56%
Total Expense0.51%0.74%0.76%0.73%0.73%
Fee Waiver0.00%-0.76%-0.66%-0.50%-0.63%
Net Expense0.51%0.60%0.63%0.63%0.60%
Receive FMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fidelity Disruptive Medicine ETF and its competitors with MarketBeat's FREE daily newsletter.

FMED ETF News Headlines

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Short Interest Update
Fidelity Disruptive Medicine ETF declares $0.112 dividend
See More Headlines

FMED ETF - Frequently Asked Questions

Fidelity Disruptive Medicine ETF's stock was trading at $24.66 at the start of the year. Since then, FMED shares have decreased by 4.5% and is now trading at $23.5450.

Fidelity Disruptive Medicine ETF's top institutional shareholders include Wealth Enhancement Advisory Services LLC (31.31%).

Shares of FMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Fund Details

Issuer
Fidelity
Fund Name
Fidelity Disruptive Medicine ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:FMED
Inception Date
6/12/2023
Fund Manager
Niamh Brodie-Machura, Camille Carlstrom, Tim Codrington,Charlie Hebard,Michael Kim, Christopher Lee,William Shanley
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
N/A
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
70

Fund Statistics

Assets Under Management
$52.71 million
Average Daily Volume
$0.00
Discount/Premium
-0.03%

Administrator, Advisor and Custodian

Administrator
Fidelity Management & Research Company, LLC
Advisor
Fidelity Management & Research Company, LLC
Custodian
State Street Bank and Trust Company
Distributor
Fidelity Distributors Company LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Jane Street

Options

Optionable
N/A
Short Interest
900 shs

Miscellaneous

Beta
1.01
Creation Fee
$200.00
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Top 10 FMED Holdings

FMED Sector Exposure

FMED Industry Exposure


This page (NASDAQ:FMED) was last updated on 8/1/2025 by MarketBeat.com Staff
From Our Partners